These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9125484)

  • 1. Immunodetection of glycoprotein hormone subunits in nonfunctioning and glycoprotein hormone-secreting pituitary adenomas.
    Saccomanno K; Bassetti M; Lania A; Losa M; Faglia G; Spada A
    J Endocrinol Invest; 1997 Feb; 20(2):59-64. PubMed ID: 9125484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas.
    Lania A; Gangi E; Romoli R; Losa M; Travaglini P; Meringolo D; Ambrosi B; Faglia G; Beck-Peccoz P; Spada A
    Eur J Clin Invest; 2002 May; 32(5):335-40. PubMed ID: 12027873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodetection of chorionic gonadotropin and its subunits in human nonfunctioning pituitary adenomas.
    Saccomanno K; Spada A; Bassetti M; Gil-del-Alamo P; Faglia G
    J Clin Endocrinol Metab; 1994 May; 78(5):1103-7. PubMed ID: 7513714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas.
    Borgato S; Persani L; Romoli R; Cortelazzi D; Spada A; Beck-Peccoz P
    J Endocrinol Invest; 1998 Jun; 21(6):372-9. PubMed ID: 9699129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
    Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas.
    Sanno N; Teramoto A; Sugiyama M; Itoh Y; Osamura RY
    Am J Clin Pathol; 1996 Jul; 106(1):16-21. PubMed ID: 8701926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro.
    Klibanski A; Alexander JM; Bikkal HA; Hsu DW; Swearingen B; Zervas NT
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1248-55. PubMed ID: 1720125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro detection of glycoprotein production and secretion by human nonfunctioning pituitary adenomas.
    Saccomanno K; Gil del Alamo P; Bassetti M; Reza-Elahi F; Spada A
    J Endocrinol Invest; 1993 Feb; 16(2):109-15. PubMed ID: 7681860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.
    Katznelson L; Alexander JM; Bikkal HA; Jameson JL; Hsu DW; Klibanski A
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1343-51. PubMed ID: 1375599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
    Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
    J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
    Popovic V; Damjanovic S
    Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro secretion of FSH by cultured clinically nonfunctioning and gonadotroph pituitary adenomas is directly correlated with locally produced levels of activin A.
    Wessels HT; Hofland LJ; van der Wal R; van Gastel L; van Koetsveld PM; de Herder WW; de Jong FH
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):485-92. PubMed ID: 11318784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical studies of human FSH producing pituitary adenomas.
    Osamura RY; Watanabe K
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):61-8. PubMed ID: 2453972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma.
    Pawlikowski Łódź M; Jaranowska M; Fryczak J; Radek M; Świętosławski J; Kunert-Radek J; Winczyk K
    Endokrynol Pol; 2018; 69(5):526-529. PubMed ID: 30074232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin and thyrotropin alpha- and beta-subunit gene expression in normal and neoplastic tissues characterized using specific messenger ribonucleic acid hybridization probes.
    Jameson JL; Lindell CM; Habener JF
    J Clin Endocrinol Metab; 1987 Feb; 64(2):319-27. PubMed ID: 3098775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas.
    Sanno N; Sugawara A; Teramoto A; Abe Y; Yen PM; Chin WW; Osamura RY
    Neuroendocrinology; 1997 Apr; 65(4):299-306. PubMed ID: 9143002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.